Clinical Research

Taking an active role — for the present and the future.

Utah Cancer Specialists is committed to clinical research.  We always have a variety of clinical studies available to our patients.  We participates in clinical research with several nationwide cooperative oncology research organizations.



Clinical research that involves the testing of a new drug progresses in an orderly series of steps, called phases. This allows researchers to ask and answer questions in a way that results in reliable information about the drug and protects the patients. Most clinical studies are classified into one of three phases:


These first studies in people evaluate how a new drug should be given (by mouth, injected into the blood,or injected into the muscle), how often, and what dose is safe. A phase I study usually enrolls only a small number of patients, sometimes as few as a dozen. Utah Cancer Specialists (UCS) does not participate in Phase 1 trials.


A phase II trial continues to test the safety of the drug, and begins to evaluate how well the new drug works. Phase II studies usually focus on a particular type of cancer. Phase II studies at Utah Cancer Specialists are very carefully monitored and consistently observed.


These studies test a new drug, OR a new combination of drugs in comparison to the current standard. Phase III STUDIES often enroll large numbers of people and may be conducted at many doctors’ offices, clinics, and cancer centers nationwide.

Additionally, after a treatment has been approved and is being marketed, we study it further in a Phase IV STUDY. The purpose of Phase IV STUDIES is to evaluate the side effects, risks, and benefits of a drug over a longer period of time. Thousands of people are involved in a Phase IV STUDY. Phase IV STUDIES at UCS are acutely scrutinized.

Contact the UCS Clinical Trials Director